Mallinckrodt distributing radiopharmaceuticals through Medi+Physics, subcontracting out NMA consultancy.
MALLINCKRODT DISTRIBUTING RADIOPHARMACEUTICALS THROUGH MEDI+PHYSICS radiopharmacies in the U.S. and Canada under an agreement signed the week of March 13, St. Louis-based Mallinckrodt announced March 20. Mallinckrodt previously signed an agreement, effective Jan. 16, to distribute Medi+Physics radiopharmaceuticals through Mallinckrodt radiopharmacies. Arlington Heights, Ill.-based Medi+Physics is the U.S. radiopharmacy unit of Amersham.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth